tiprankstipranks
Advertisement
Advertisement

MIRM Stock Latest News

Mirum Pharmaceuticals price target raised to $125 from $115 at JPMorgan
The FlyMirum Pharmaceuticals price target raised to $125 from $115 at JPMorgan
2d ago
MIRM
Mirum Shareholders Approve Directors, Auditors and Compensation
PremiumCompany Announcements
Mirum Shareholders Approve Directors, Auditors and Compensation
16d ago
8K
MIRM
Mirum Therapeutics: Strong FOP Data and Priority Review Support Buy Rating and Unchanged $150 Price Target
PremiumRatings
Mirum Therapeutics: Strong FOP Data and Priority Review Support Buy Rating and Unchanged $150 Price Target
19d ago
MIRM
Buy Rating Reiterated on Mirum Pharmaceuticals as Zilurgisertib Data De-Risk Pipeline; $145 Price Target Unchanged with ~46% Upside Potential
PremiumRatings
Buy Rating Reiterated on Mirum Pharmaceuticals as Zilurgisertib Data De-Risk Pipeline; $145 Price Target Unchanged with ~46% Upside Potential
19d ago
MIRM
Mirum Pharmaceuticals price target raised to $146 from $140 at Citizens
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $146 from $140 at Citizens
19d ago
MIRM
Incyte, Mirum announces Phase 2 results from Cohort 1 of Progress study
PremiumThe FlyIncyte, Mirum announces Phase 2 results from Cohort 1 of Progress study
20d ago
INCY
MIRM
Mirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley
Premium
The Fly
Mirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley
23d ago
VIR
MIRM
Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley
Premium
The Fly
Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley
23d ago
VIR
MIRM
Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026
PremiumThe Fly
Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026
30d ago
INCY
MIRM
Mirum Expands Long-Term Safety Data for Livmarli in Rare Pediatric Liver Diseases
PremiumCompany Announcements
Mirum Expands Long-Term Safety Data for Livmarli in Rare Pediatric Liver Diseases
1M ago
MIRM
Mirum Pharmaceuticals initiated with a Buy at Citi
PremiumThe Fly
Mirum Pharmaceuticals initiated with a Buy at Citi
1M ago
MIRM
Mirum Pharma Earns Buy Rating on Strong Volixibat Phase 2b PSC Data and De-Risked Regulatory Path
PremiumRatings
Mirum Pharma Earns Buy Rating on Strong Volixibat Phase 2b PSC Data and De-Risked Regulatory Path
1M ago
MIRM
Mirum announces new data from its rare liver disease programs at EASL
PremiumThe FlyMirum announces new data from its rare liver disease programs at EASL
1M ago
MIRM
Mirum Pharmaceuticals Balances Rapid Growth and Heavy Spend
Premium
Company Announcements
Mirum Pharmaceuticals Balances Rapid Growth and Heavy Spend
2M ago
MIRM
Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research
Premium
The Fly
Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research
2M ago
MIRM
Mirum Pharmaceuticals Issues $690 Million Convertible Senior Notes
PremiumCompany Announcements
Mirum Pharmaceuticals Issues $690 Million Convertible Senior Notes
2M ago
8K
MIRM
Mirum Pharmaceuticals announces $600M convertible senior notes offering
PremiumThe Fly
Mirum Pharmaceuticals announces $600M convertible senior notes offering
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $165 from $164 at Raymond James
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $165 from $164 at Raymond James
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $145 from $125 at TD Cowen
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $145 from $125 at TD Cowen
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $142 from $128 at RBC Capital
PremiumThe FlyMirum Pharmaceuticals price target raised to $142 from $128 at RBC Capital
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $129 from $112 at Baird
Premium
The Fly
Mirum Pharmaceuticals price target raised to $129 from $112 at Baird
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $136 from $130 at Stifel
Premium
The Fly
Mirum Pharmaceuticals price target raised to $136 from $130 at Stifel
2M ago
MIRM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >